Home Random Page


CATEGORIES:

BiologyChemistryConstructionCultureEcologyEconomyElectronicsFinanceGeographyHistoryInformaticsLawMathematicsMechanicsMedicineOtherPedagogyPhilosophyPhysicsPolicyPsychologySociologySportTourism






or worsening oxygenation. Dexamethasone is not recommended to treat critical

illness-related corticosteroid insufficiency. The role of glucocorticoids in the

management of patients with community-acquired pneumonia, liver failure,

pancreatitis, those undergoing cardiac surgery, and other groups of critically

ill patients requires further investigation.

 

 

Sepse 2009

 

studie NICE SUGAR glykemie cca mezi 4-6 mmol/L zvyšuje smrtnost ve srovnání s hodnotami cca 6-10

Intensive versus conventional glucose control in critically ill patients.

NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ.

Collaborators (203)

BACKGROUND: The optimal target range for blood glucose in critically ill patients remains unclear. METHODS: Within 24 hours after admission to an intensive care unit (ICU), adults who were expected to require treatment in the ICU on 3 or more consecutive days were randomly assigned to undergo either intensive glucose control, with a target blood glucose range of 81 to 108 mg per deciliter (4.5 to 6.0 mmol per liter), or conventional glucose control, with a target of 180 mg or less per deciliter (10.0 mmol or less per liter). We defined the primary end point as death from any cause within 90 days after randomization. RESULTS: Of the 6104 patients who underwent randomization, 3054 were assigned to undergo intensive control and 3050 to undergo conventional control; data with regard to the primary outcome at day 90 were available for 3010 and 3012 patients, respectively. The two groups had similar characteristics at baseline. A total of 829 patients (27.5%) in the intensive-control group and 751 (24.9%) in the conventional-control group died (odds ratio for intensive control, 1.14; 95% confidence interval, 1.02 to 1.28; P=0.02). The treatment effect did not differ significantly between operative (surgical) patients and nonoperative (medical) patients (odds ratio for death in the intensive-control group, 1.31 and 1.07, respectively; P=0.10). Severe hypoglycemia (blood glucose level, < or = 40 mg per deciliter [2.2 mmol per liter]) was reported in 206 of 3016 patients (6.8%) in the intensive-control group and 15 of 3014 (0.5%) in the conventional-control group (P<0.001). There was no significant difference between the two treatment groups in the median number of days in the ICU (P=0.84) or hospital (P=0.86) or the median number of days of mechanical ventilation (P=0.56) or renal-replacement therapy (P=0.39). CONCLUSIONS: In this large, international, randomized trial, we found that intensive glucose control increased mortality among adults in the ICU: a blood glucose target of 180 mg or less per deciliter resulted in lower mortality than did a target of 81 to 108 mg per deciliter.(ClinicalTrials.gov number, NCT00220987.) 2009 Massachusetts



 

Recentní studie NICE SUGAR uvádí nižší mortalitu u pacientů s cílovou glykemii 10 mmol/L ve srovnání s pacienty kde byla udržována cílová hodnota glykemie 81 mg-108 mg/dL (N Engl J Med. 2009 Mar 26;360(13):1283-97. Epub 2009 Mar 24.

 

 


Date: 2016-01-05; view: 520


<== previous page | next page ==>
Force by the American College of Critical Care Medicine. | Table B.1 Correspondence between ISO 14001:2004 and ISO 9001:2000
doclecture.net - lectures - 2014-2020 year. Copyright infringement or personal data (0.003 sec.)